Загрузка...
The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade in Solid Malignancies
There have been unprecedented advances in the treatment of cancer through the use of immunotherapy, with several agents now FDA-approved for use in widespread metastatic disease across cancer types. Immune checkpoint blockade represents a particularly promising class of agents that block inhibitory...
Сохранить в:
| Опубликовано в: : | Ann Surg Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6105272/ https://ncbi.nlm.nih.gov/pubmed/29500764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6379-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|